News
By creating a permanent commission on prescription drugs, Congress could break its reliance on the pharmaceutical industry for drug policy ideas.
SAN DIEGO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary ...
NMD Pharma announces poster and oral presentations on skeletal muscle targeted ClC-1 therapy at two leading neuromuscular disease conferences ClC-1 is a chloride ion channel specifically expressed ...
Congress is considering capping what seniors can pay out of pocket each year at the pharmacy counter through Medicare Part D, an idea pharma supports.
Nuvectis Pharma Recaps Poster Presentation Highlights for NXP800 at the 2023 ESMO Gynecological Cancers Congress Feb. 23, 2023 8:00 AM ET Nuvectis Pharma, Inc. (NVCT) GlobeNewswire ...
Why is Congress continuing to help Big Pharma avoid accountability and suck every penny it can from Main Street?
Tris will be presenting new pharmacokinetics and palatability assessment data from a recently-completed study on amphetamine extended-release tablets. The titles of the posters, to be presented on ...
JERUSALEM, Sept. 16, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that two posters in support of the Company's Phase 3 clinical development ...
Actinium's technology platform is the basis for collaborations with Astellas Pharma for solid tumors, AVEO Oncology/LG Chem Life Sciences for HER3 solid tumors, and EpicentRx for its CD47 ...
4D pharma Presents Two Clinical Posters for Live Biotherapeutic MRx0518 at the European Society for Medical Oncology (ESMO) Congress 2021 ...
Poster on the results of patients’ freedom from pain and most bothersome symptom when taking Qtrypta concurrently with prophylactic anti-CGRP antibodies.
Prior to this political transition, pharmaceutical patent reform garnered renewed attention in the 118th Congress, signaling that legislative efforts in this field remain a priority to those in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results